Highlights in gastro-intestinal cancer

Bron
Belgian journal of medical oncology - ISSN 1784-7141-12 (2018) p. 182-188
Auteur(s)

A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness

Bron
European journal of cancer - ISSN 0959-8049-202 (2024) p. 1-13
Auteur(s)
    Takayuki Yoshino, Naushin Hooda, Diana Younan, Kei Muro, Kohei Shitara, Volker Heinemann, Bert Howard O'neil, Fernando Rivera Herrero, Marc Peeters, Junpei Soeda, Mina Suh, Heidi Reichert, Khalid Mezzi, Jon Fryzek, Victoria Chia, Marko Rehn, Sebastian Stintzing

Auranofin repurposing for lung and pancreatic cancer : low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition

Bron
Journal of Experimental and Clinical Cancer Research - ISSN 1756-9966-43:1 (2024) p. 1-15

Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database

Bron
The British journal of cancer - ISSN 0007-0920-130 (2024) p. 1269-1278
Auteur(s)
    C.S. Karapetis, H. Liu, M.J. Sorich, L.D. Pederson, E. Van Cutsem, T. Maughan, J.Y. Douillard, C.J. O'Callaghan, D. Jonker, C. Bokemeyer, A. Sobrero, C. Cremolini, B. Chibaudel, J. Zalcberg, R. Adams, M. Buyse, Marc Peeters, T. Yoshino, A. de Gramont, Q. Shi

Hyperthermia in combination with emerging targeted and immunotherapies as a new approach in cancer treatment

Bron
Cancers - ISSN 2072-6694-16:3 (2024) p. 1-35
Auteur(s)